share

2-(4-Allyl-1-Piperazinyl)-4-Butoxyquinazoline Fumarate (2:3) CAS NO 129663-99-6


Unit Price:

CAS No.:129663-99-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

2-(4-Allyl-1-Piperazinyl)-4-Butoxyquinazoline Fumarate (2:3) is a high-purity, non-stoichiometric salt complex of a quinazoline derivative, designed for advanced research and development applications. This compound is valued for its specific molecular architecture, which is critical for investigating structure-activity relationships in pharmaceutical discovery. It serves as a key synthetic intermediate or reference standard for researchers in medicinal chemistry and pharmacology, particularly those focused on central nervous system (CNS) targets and receptor modulation.

Application

  • Pharmaceutical R&D Intermediate: Serves as a crucial building block in the synthesis of novel therapeutic candidates, particularly for neurological and psychiatric disorders.
  • Medicinal Chemistry Reference Standard: Used as a high-purity standard for analytical method development, validation, and quality control in drug discovery pipelines.
  • Biochemical Research: Employed in in vitro studies to explore interactions with specific enzyme systems or receptor subtypes relevant to its pharmacophore.
  • Academic Research: Utilized in university and institutional labs for fundamental research into heterocyclic chemistry and drug-receptor kinetics.
  • Process Chemistry Development: Acts as a model compound for scaling up synthetic routes and optimizing purification processes in pre-clinical development.

Basic Information

Product Name 2-(4-Allyl-1-Piperazinyl)-4-Butoxyquinazoline Fumarate (2:3)
CAS No. 129663-99-6
Molecular Formula C19H26N4O • 1.5 C4H4O4
Molecular Weight ~ 574.62 g/mol (for the 2:3 salt complex)
Synonyms 4-Butoxy-2-(4-allyl-1-piperazinyl)quinazoline fumarate (2:3); 2-(4-Allylpiperazin-1-yl)-4-butoxyquinazoline fumarate (2:3); Quinazoline, 2-(4-allyl-1-piperazinyl)-4-butoxy-, (E)-2-butenedioate (2:3); 129663-99-6; UNII-8V3Y0F2V7F
EINECS Contact for details

Quality Control

Our 2-(4-Allyl-1-Piperazinyl)-4-Butoxyquinazoline Fumarate (2:3) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. A detailed Certificate of Analysis (COA) is provided with every shipment, ensuring traceability and compliance with your research-grade specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is hygroscopic (moisture-sensitive); ensure the container is sealed under an inert atmosphere after each use to maintain stability and prevent degradation.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Complies with ICH guidelines
Heavy Metals < 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.